Bioadaptives Stock Today
| BDPT Stock | USD 0.02 0.01 33.80% |
PerformanceSoft
| Odds Of DistressRisky
|
BioAdaptives is selling for under 0.0188 as of the 23rd of January 2026; that is 33.8 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.0188. BioAdaptives has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 25th of October 2025 and ending today, the 23rd of January 2026. Click here to learn more.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. The company has 160.49 M outstanding shares. More on BioAdaptives
Moving against BioAdaptives Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioAdaptives Pink Sheet Highlights
| Thematic Idea | Penny (View all Themes) |
| Business Concentration | Penny, Packaged Foods, Consumer Defensive (View all Sectors) |
BioAdaptives [BDPT] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 144.44 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioAdaptives's market, we take the total number of its shares issued and multiply it by BioAdaptives's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioAdaptives conducts business under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 160.49 M outstanding shares.
BioAdaptives currently holds about 49.58 K in cash with (158.65 K) of positive cash flow from operations.
Check BioAdaptives Probability Of Bankruptcy
Ownership AllocationBioAdaptives holds a total of 160.49 Million outstanding shares. BioAdaptives shows 7.4 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioAdaptives Ownership Details
BioAdaptives Risk Profiles
| Mean Deviation | 11.78 | |||
| Semi Deviation | 13.58 | |||
| Standard Deviation | 18.54 | |||
| Variance | 343.55 |
BioAdaptives Stock Against Markets
BioAdaptives Pink Sheet Analysis Notes
The company recorded a loss per share of 0.02. BioAdaptives had not issued any dividends in recent years. BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for BioAdaptives is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BioAdaptives please contact MD Jacobs at 702 659 8829 or go to https://www.shopbioadaptives.com.BioAdaptives Investment Alerts
| BioAdaptives is way too risky over 90 days horizon | |
| BioAdaptives has some characteristics of a very speculative penny stock | |
| BioAdaptives appears to be risky and price may revert if volatility continues | |
| BioAdaptives has a very high chance of going through financial distress in the upcoming years | |
| BioAdaptives currently holds 450.26 K in liabilities. BioAdaptives has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioAdaptives until it has trouble settling it off, either with new capital or with free cash flow. So, BioAdaptives' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioAdaptives sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioAdaptives to invest in growth at high rates of return. When we think about BioAdaptives' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 19.78 K. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 10.11 K. | |
| BioAdaptives currently holds about 49.58 K in cash with (158.65 K) of positive cash flow from operations. |
BioAdaptives Thematic Classifications
In addition to having BioAdaptives pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | PennyStrong penny or near-penny equities |
BioAdaptives Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 144.44 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioAdaptives's market, we take the total number of its shares issued and multiply it by BioAdaptives's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 23rd of January, BioAdaptives shows the Mean Deviation of 11.78, downside deviation of 19.05, and Risk Adjusted Performance of 0.0513. BioAdaptives technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioAdaptives Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioAdaptives Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe BioAdaptives price patterns.
BioAdaptives Outstanding Bonds
BioAdaptives issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioAdaptives uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioAdaptives bonds can be classified according to their maturity, which is the date when BioAdaptives has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
BioAdaptives Predictive Daily Indicators
BioAdaptives intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioAdaptives pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 109.47 | |||
| Daily Balance Of Power | (48.00) | |||
| Rate Of Daily Change | 0.66 | |||
| Day Median Price | 0.0189 | |||
| Day Typical Price | 0.0189 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 45.52 |
BioAdaptives Forecast Models
BioAdaptives' time-series forecasting models are one of many BioAdaptives' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioAdaptives' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in BioAdaptives without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.